Viquglip-M
Description_Effects
Viquglip-M is an oral anti-diabetic medication that combines Vildagliptin (50mg) and Metformin (500mg) to effectively manage type 2 diabetes mellitus in adults. This dual-action formula helps control blood sugar levels in individuals who are unable to manage their diabetes with diet and exercise alone or with monotherapy. Metformin, a biguanide, works by decreasing glucose production in the liver, slowing intestinal glucose absorption, and improving insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, increases the release of insulin and reduces the secretion of glucagon in response to meals. Together, these actions help regulate blood glucose levels throughout the day. Maintaining optimal blood sugar levels is essential for preventing serious diabetes-related complications like kidney failure, nerve damage, vision loss, and limb amputation. Additionally, good glycemic control significantly lowers the risk of heart disease and stroke. Viquglip-M is most effective when used in combination with a healthy diet, regular physical activity, and routine monitoring of blood glucose levels. It should be taken exactly as prescribed by your healthcare provider. Continuing this medication as directed helps protect long-term health and allows individuals with diabetes to lead a healthier, more active life.
